当前位置:首页>>博士后之家>>国外博士后招聘>>正文内容

美国德州大学安德森癌症中心博士后职位

2019年02月25日
来源:知识人网整理
摘要:博士后研究员职位可在MD安德森癌症中心的李马博士实验室获得。自2010年成立以来,Ma Lab在建立microRNA介导的转移,上皮 - 间质转化和治疗抗性调控模型中发挥了重要作用(Nature Medicine 2012,PLoS Genetics 2014,Nature Communications 2014,Cancer Research 2016,等),并纠正长非编码RNA(lncRNA)转移调控模型(Nature Genetics 2018 - 一个范式转换研究,建立严格表征lncRNAs的框架)。

  招聘简介:

  MD安德森癌症中心的博士后职位(RNA和转移研究)

  博士后研究员职位可在MD安德森癌症中心的李马博士实验室获得(https://faculty.mdanderson.org/profiles/li_ma.html)。自2010年成立以来,Ma Lab在建立microRNA介导的转移,上皮 - 间质转化和治疗抗性调控模型中发挥了重要作用(Nature Medicine 2012,PLoS Genetics 2014,Nature Communications 2014,Cancer Research 2016,等),并纠正长非编码RNA(lncRNA)转移调控模型(Nature Genetics 2018  - 一个范式转换研究,建立严格表征lncRNAs的框架)。除了与RNA相关的研究外,Ma Lab还发现了关键癌症蛋白的去泛素化酶;这些去泛素化酶中的一些是有希望的抗肿瘤和抗转移靶标(Nature Cell Biology 2013,Nature Cell Biology 2014,Cell Reports 2018,Nature Communications 2018等)。我们的工作得到了许多团体的证实和引用(Ma博士的Google学术搜索引用次数:2018年的10,000次)。来自这个实验室的多位前博士后已经获得了独立的教师职位。

  英文原文:

  Postdoctoral positions (RNA and metastasis research) at MD Anderson Cancer Center

  Postdoctoral Fellow positions are available in Dr. Li Ma’s laboratory at MD Anderson Cancer Center (https://faculty.mdanderson.org/profiles/li_ma.html). Since its founding in 2010, the Ma Lab has played a major role in establishing models of microRNA-mediated regulation of metastasis, epithelial-mesenchymal transition, and therapy resistance (Nature Medicine 2012, PLoS Genetics 2014, Nature Communications 2014, Cancer Research 2016, etc), and in rectifying models of long non-coding RNA (lncRNA) regulation of metastasis (Nature Genetics 2018 – a paradigm-shifting study that establishes the framework for rigorous characterization of lncRNAs). In addition to RNA-related research, the Ma Lab also discovered the deubiquitinases for key cancer proteins; some of these deubiquitinases are promising anti-tumor and anti-metastatic targets (Nature Cell Biology 2013, Nature Cell Biology 2014, Cell Reports 2018, Nature Communications 2018, etc). Our work has been confirmed and cited by many groups (Dr. Ma’s Google Scholar citations: 10,000 as of 2018). Multiple former postdocs from this lab have landed independent faculty positions.

  Current interests include: (1) establishing new paradigms for RNA functions and mechanisms in tumor progression and metastasis; (2) screening for deubiquitinating enzymes that promote tumorigenesis, metastasis, or therapy resistance; and (3) investigating novel regulators and regulations of tumor radioresistance, drug resistance, and anti-tumor immunity.

  We consider highly motivated and creative candidates with a recently obtained Ph.D. degree and strong first-author publications. For those interested, please send a CV, three letters of recommendation, and a research statement (limalab2018@gmail.com).

  MD Anderson Cancer Center is an equal opportunity employer and does not discriminate on the basis of race, color, national origin, gender, sexual orientation, age, religion, disability or veteran status except where such distinction is required by law. All positions at The University of Texas MD Anderson Cancer Center are security sensitive and subject to examination of criminal history record information. Smoke-free and drug-free environment.

  Li Ma, Ph.D.

  Associate Professor

  The University of Texas MD Anderson Cancer Center

  Experimental Radiation Oncology – Unit 1052

  Houston, TX 77030-4009